Emedi Pharmaceuticals Private Limited, a active private limited company, was established on 03 July 2015 in Patna, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909BR2015PTC024534. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 49 professional, Its leadership includes Kumud Kamini (Director), Tarun Kumar Singh (Director), Ravi Shankar (Director). Past directors included Basant Kumar Singh, Dilasa Kumari. It holds ₹1.35 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H/O Smt. Kanchan Kumari, Fci Colony South Of Transport Nagar, Agam Kuan, Patna, Bihar, 800007.
U51909BR2015PTC024534
024534
03 July 2015
₹1.50 M
₹1.00 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Emedi Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kumud Kamini | Director | 03 Jul 2015 | Current |
| Tarun Kumar Singh | Director | 03 Jul 2015 | Current |
| Ravi Shankar | Director | 03 Jul 2015 | Current |
| Rahul Kumar Singh | Director | 21 Nov 2015 | Current |
| Santosh Kumar Singh | Managing Director | 21 Nov 2015 | Current |
| Neeraj Kumar | Director | 21 Nov 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Aug 2016 | Past |
| Pramod Abcsdd | Director | 06 Aug 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Emedi Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.11% increase. The company also saw a substantial improvement in profitability, with a 13.61% increase in profit. The company's net worth Soared by an impressive increase of 33.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Emedi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹13,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2022 | Hdfc Bank Limited | ₹1.25 Cr | Open |
| 09 Feb 2016 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Emedi Pharmaceuticals has a workforce of 49 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Emedi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emedi Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited of Rs. 12.50 M registered on 31 Jan 2022 with Charge ID 100561236 was modified on 28 Jan 2025. was recorded as a recent event.
Progress on Emedi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Emedi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 12.50 M with Charge ID 100561236 was registered on 31 Jan 2022. was documented.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100028699 was registered on 09 Feb 2016. was recorded as a recent event.
Progress on Rahul Kumar Singh was appointed as a Director was appointed as a Director on 21 Nov 2015 & has been associated with this company since 10 years 1 month . was documented.
The CIN of Emedi Pharmaceuticals Private Limited is U51909BR2015PTC024534.
Emedi Pharmaceuticals Private Limited is headquartered at H/O Smt. Kanchan Kumari, Fci Colony South Of Transport Nagar, Agam Kuan, Patna, Bihar, 800007.
Emedi Pharmaceuticals Private Limited was incorporated on 03 July 2015.
The current directors of Emedi Pharmaceuticals Private Limited are
The primary industry of Emedi Pharmaceuticals Private Limited is Trade.
Emedi Pharmaceuticals Private Limited is unlisted.
The authorized capital of Emedi Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Emedi Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX